AMN Healthcare Services, Inc. Aktie News

DALLAS, May 27, 2025 (GLOBE NEWSWIRE) -- The time required to schedule a physician appointment in 15 major metropolitan areas has increased by 19% since 2022 and by 48% since 2004, according to a new survey conducted by AMN Healthcare, the nation's leading healthcare workforce solutions company.

Heart of Healthcare Under Pressure: 1 in 3 Nurses Near Retirement as Continued Volatility Persists Heart of Healthcare Under Pressure: 1 in 3 Nurses Near Retirement as Continued Volatility Persists

AMN Healthcare Services, Inc. (NYSE:AMN ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Randle Reece - Senior Director of Investor Relations and Strategy Cary Grace - President and Chief Executive Officer Brian Scott - Chief Financial Officer and Chief Operating Officer Conference Call Participants Mark Marcon - Baird Trevor Romeo - William Blair A.J. Rice - UBS M...

Quarterly revenue of $690 million;  GAAP loss of ($0.03)/share and adjusted EPS of $0.45

Early indicators from competitors and customers suggest a revenue beat in Q1 2025, and likely a bottom in the healthcare staffing market. HCA's spend on contract labor (which has moved in line with AMN's revenue for 4 of the last 5 quarters) came in at -10.5%, while analysts expect an 18% decline. AMN trades at a P/S ratio (0.26x) not seen since the GFC.

DALLAS, April 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2025 financial results and second quarter 2025 outlook on Thursday, May 8, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.

DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Close to half of hospital, medical group and other healthcare facility leaders intend to leave their organizations during the next 12 months, according to a new survey examining the plans, perspectives and challenges facing healthcare executives in 2025. Conducted by B.E.

After a contextually positive Q4, shares continue to trade at an attractive valuation. Recent demand trends and commentary increasingly suggest demand is finding a stabilization point. Macro and M&A risks remain, but today's price offers an attractive IRR, all things considered.